Research Article
Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice
Table 5
Statistical analysis of the results presented in Figure
5.
(a) |
| One-way ANOVA | Source of variation | % of total variation | value | value summary | Significant? |
| Interaction | 1.53 | 0.0101 | * | Yes | Drug | 4.25 | <0.0001 | *** | Yes |
|
|
(b) |
| Bonferroni test | Mean difference | | value | Summary |
| Control versus sulindac | −6.000 | 0.5758 | > 0.05 | ns | Control versus PERVIVO | −16.00 | 1.535 | > 0.05 | ns | Control versus sulindac + PERVIVO | −58.00 | 6.935 | < 0.001 | *** | Sulindac versus sulindac + PERVIVO | −52.00 | 4.990 | < 0.001 | *** | PERVIVO versus sulindac + PERVIVO | −42.00 | 4.030 | < 0.001 | *** | Control versus sulindac | −6.000 | 0.5758 | > 0.05 | ns | Control versus PERVIVO | −16.00 | 1.535 | > 0.05 | ns | Control versus sulindac + PERVIVO | −58.00 | 6.935 | < 0.001 | *** | Sulindac versus sulindac + PERVIVO | −52.00 | 4.990 | < 0.001 | *** | PERVIVO versus sulindac + PERVIVO | −42.00 | 4.030 | < 0.001 | *** |
|
|
, ***.
|